ATE427653T1 - Stabilisierung der milch transgener tieren - Google Patents

Stabilisierung der milch transgener tieren

Info

Publication number
ATE427653T1
ATE427653T1 AT99972491T AT99972491T ATE427653T1 AT E427653 T1 ATE427653 T1 AT E427653T1 AT 99972491 T AT99972491 T AT 99972491T AT 99972491 T AT99972491 T AT 99972491T AT E427653 T1 ATE427653 T1 AT E427653T1
Authority
AT
Austria
Prior art keywords
milk
transgenic animals
stabilization
relates
antitrypsin
Prior art date
Application number
AT99972491T
Other languages
English (en)
Inventor
Ian Cottingham
Graham Mccreath
Original Assignee
Pharming Intellectual Pty Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26314697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE427653(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9825374.3A external-priority patent/GB9825374D0/en
Application filed by Pharming Intellectual Pty Bv filed Critical Pharming Intellectual Pty Bv
Application granted granted Critical
Publication of ATE427653T1 publication Critical patent/ATE427653T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/103—Ovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
AT99972491T 1998-11-19 1999-11-19 Stabilisierung der milch transgener tieren ATE427653T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9825374.3A GB9825374D0 (en) 1998-11-19 1998-11-19 Method
US12854699P 1999-04-09 1999-04-09

Publications (1)

Publication Number Publication Date
ATE427653T1 true ATE427653T1 (de) 2009-04-15

Family

ID=26314697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972491T ATE427653T1 (de) 1998-11-19 1999-11-19 Stabilisierung der milch transgener tieren

Country Status (8)

Country Link
EP (1) EP1130961B1 (de)
JP (1) JP2011167196A (de)
AT (1) ATE427653T1 (de)
AU (1) AU765315B2 (de)
CA (1) CA2351943A1 (de)
DE (1) DE69940700D1 (de)
NZ (1) NZ511299A (de)
WO (1) WO2000030436A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2547337A1 (de) 2010-03-17 2013-01-23 Pharming Intellectual Property B.V. Verwendung von antikoagulanzien bei der herstellung von rekombinanten proteinen in der milch von transgenen tieren
AU2012323992A1 (en) * 2011-12-19 2013-07-04 Lfb Usa, Inc. Recombinant human alpha-1-antitrypsin for the treatment of inflammatory disorders
EP2956003A2 (de) 2013-02-13 2015-12-23 Laboratoire Français du Fractionnement et des Biotechnologies Proteine mit modifizierter glykosylierung und verfahren zur herstellung davon
KR20160002713A (ko) 2013-02-13 2016-01-08 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
US10208101B2 (en) 2013-12-27 2019-02-19 Japan Blood Products Organization Recombinant fibrinogen high-production line and method for producing same
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
CN112666112A (zh) * 2020-10-01 2021-04-16 华中农业大学 骆驼奶与马奶的批量鉴别模型和方法
CN112525850A (zh) * 2020-10-01 2021-03-19 华中农业大学 奶牛奶、马奶、骆驼奶、山羊奶和水牛奶的光谱指纹识别方法
CN112666113A (zh) * 2020-10-01 2021-04-16 华中农业大学 山羊奶和马奶的快速鉴别方法
CN112666111A (zh) * 2020-10-01 2021-04-16 华中农业大学 奶牛奶与马奶的快速鉴别方法
CN112666114A (zh) * 2020-10-01 2021-04-16 华中农业大学 利用光谱识别水牛奶与马奶的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9028062D0 (en) * 1990-12-24 1991-02-13 Agricultural & Food Res Production of transgenic animals
US5272074A (en) 1992-04-23 1993-12-21 Mcmaster University Fibrin coated polymer surfaces
AU693436B2 (en) * 1993-03-09 1998-07-02 Genzyme Corporation Isolation of components of interest from milk
PT744891E (pt) * 1994-02-18 2008-01-14 Virginia Tech Intell Prop Fibrinogénio transgénico
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
US5880327A (en) * 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517780D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
SE9601091L (sv) * 1996-03-21 1997-09-22 Joyce Carlson Användning av en proteinsubstans för bindning av steroid-liknande molekyler

Also Published As

Publication number Publication date
EP1130961B1 (de) 2009-04-08
NZ511299A (en) 2003-02-28
CA2351943A1 (en) 2000-06-02
AU765315B2 (en) 2003-09-18
DE69940700D1 (de) 2009-05-20
WO2000030436A1 (en) 2000-06-02
AU1395600A (en) 2000-06-13
JP2011167196A (ja) 2011-09-01
EP1130961A1 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
ATE442843T1 (de) Verwendung von c-terminal modifizierter oxamyl dipeptide als inhibitoren von der ice/ced-3 familie von cystein proteasen
ATE193304T1 (de) Inhibitoren der menschlichen neutrophilenelastase
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
DE69940700D1 (de) Stabilisierung der milch transgener tieren
NO942064L (no) yminhibitorer
DK1202743T3 (da) Farmaceutiske og kosmetiske sammensætninger omfattende serinproteaser fra torsk og deres farmaceutiske og kosmetiske anvendelse
WO1998024806A3 (en) Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
NO20004696D0 (no) Kinoloner som serinproteaseinhibitorer
DK0462207T3 (da) t-Pa mutanter resistente mod deres respektive inhibitorer
DE50002836D1 (de) Substituierte anilinverbindungen
DE60128731D1 (de) Tripeptidylpeptidase-hemmer
ATE232873T1 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
BG104885A (en) Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
FI942625A0 (fi) Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina
TR200002932T2 (tr) Azabisayklik 5HT1 Alıcı liganolları
DE60002733D1 (de) Diester prodrugs von decahydroischinoline-3-carbonsäure
ATE260246T1 (de) Selektive inhibitoren des urokinase-plasminogen aktivators
DK1097233T3 (da) Promotor for vækstdifferentieringsfaktor og anvendelser deraf
SE0102921D0 (sv) Pharmaceutically useful compounds
WO1998020034A3 (en) Novel serine protease inhibitor nucleic acid molecules, proteins and uses thereof
MY137258A (en) Bacterial insecticidal protein
ATE223405T1 (de) Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)- nipecotinsäure
WO2003097593A3 (en) Protease inhibitors
SE0303120D0 (sv) Novel alkaline protease
WO2002010124A3 (en) Salt forms of an hiv protease inhibitor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties